Kazia Therapeutics switches ADR depositary to JPMorgan; Nasdaq-listed ADSs stay under KZIA
K
KZIA• ADR depositary change to JPMorgan
Kazia Therapeutics appointed JPMorgan Chase Bank as sole depositary for its ADR program, replacing , effective Sept. 18, 2026.
BNY Mellon
ADSs continue trading on Nasdaq under KZIA, with each ADS representing 500 ordinary shares.
No action is required for existing ADS holders; the transition is expected to be seamless with no interruption to positions.
CNEY
•
Kazia Therapeutics switches ADR depositary to JPMorgan; Nasdaq-listed ADSs stay under KZIA - KZIA News | Rallies
